Cite Filings / PLX / 0001104659-20-048223

Feed Companies Filings Check

Sign in

S-3

Registration Statement

Protalix BioTherapeutics, Inc. Filed 2020-04-17 Acc 0001104659-20-048223

Documents 1

S-3 Registration Statement , tm2016066d1_s3.htm

Around this filing

2022-04-20 S-3 Registration Statement
2020-04-22 UPLOAD SEC-generated Letter
2020-04-17 S-3 Registration Statement
2020-04-15 DEF 14A Proxy Statement
2020-04-13 4 Director bought 64,000 shares at $2.43 ($155,264)
2019-03-29 S-3 Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2016066d1_s3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…